Nycomed Articles
Life sciences sales lift Nycomed Amersham
13 August 1999
1st approval for Diatide's NeoTect in USA
5 August 1999
Nycomed Pharma names new chairman
24 June 1999
Nycomed Amersham Sells Diatide Stock
17 June 1999
Stock Commentary Europe
17 June 1999
PerBio Science makes bid for Endogen
3 June 1999
Stock Commentary Europe
20 May 1999
Nycomed sells pharma unit to Nordic Capital
6 May 1999
-Nycomed Amersham appointments
15 April 1999
Euro pharma sector underperformance in February
29 March 1999
Stock Commentary Europe
18 March 1999
Nycomed Amersham profits climb 12%
10 March 1999
Future growth of the global pharmaceutical market evaluated by MSDW
23 February 1999
Diatide on road to profitability with its target-and-treat strategy
11 February 1999
Diatide's NeoTect approvable says FDA - updated story
7 January 1999
Stock Commentary Europe
7 January 1999
Nycomed Amersham wins $150 mill US deal
4 January 1999
Diatide's NeoTect approvable says FDA
21 December 1998
Two New Product Approvals For Nycomed
11 December 1998
Stock Commentary Europe
10 December 1998
Nycomed-Amersham Getting Over Transformation
4 December 1998
Nycomed Signs Lucrative US Contract
21 October 1998
Diatide/Nycomed Amersham Launch AcuTect
12 October 1998
Diatide's AcuTect Approved By FDA
23 September 1998
Nycomed Amersham Acquires Molecular Dynamics.
17 September 1998
Stock Commentary Europe
10 September 1998
Nycomed Amersham Pulls Out Of Diatide Deal
21 August 1998
Stock Commentary Europe
20 August 1998
Nycomed Amersham To Buy Molecular Dynamics
11 August 1998
Stock Commentary Europe
25 June 1998
Stock Commentary Europe
18 June 1998
Stock Commentary Europe
15 June 1998
Stock Commentary Europe
4 June 1998
FDA Panel Votes Against Medeva's AD32
4 June 1998
European And London Stock Comment
21 May 1998
Nycomed Amersham Early-Year Growth "As Expected"
19 May 1998
Lehman Health Care Conference
27 April 1998
Ultrasound Patent Infringement Claim Filed By Nycomed
27 April 1998
$360M Pharma Investment In China's Pudong Region
17 April 1998
Nycomed Amersham Pretax Profits Up 9.1% For 1997
25 March 1998
AEA Technology Buys Nycomed Amersham's QSA Unit
23 February 1998
Medeva Bladder Cancer Drug Filed In USA
15 January 1998
Stock Commentary Europe
15 January 1998
Diatide's AcuTect Set For FDA Panel Review
13 January 1998
Majors Moving Away From Acquisitions & Mergers
12 January 1998
Majors Moving Away From Acquisitions & Mergers
6 January 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
Appointment At Nycomed Amersham
4 December 1997
Stock Commentary Europe
20 November 1997
Good Performance For Nycomed And Amersham
13 November 1997
Stock Commentary Europe
30 October 1997
Nycomed And Amersham Merger Approved
23 October 1997
Nycomed Tax Claim May Be Cut
23 September 1997
Growing Foreign Presence In China's Pharma Industry
22 September 1997
Nycomed Wins Contrast Media Agreement In USA
16 September 1997
Nycomed Files Patent Claims Against Competitors
11 September 1997
3 Bidders For Stake In Polish Drug Firm
14 August 1997
European and London Stock Comment
14 August 1997
Nycomed Reports Profit Rise For 2nd Qtr
11 August 1997
European And London Stock Comment
10 July 1997
Stock Commentary Europe
3 July 1997
Amersham International And Nycomed To Merge
2 July 1997
EC CPMP Plenary Meeting In June
27 June 1997
Nycomed's Teslascan Gets EU Clearance
12 June 1997
Nycomed's 1st Qtr In Line With Expectations
12 May 1997
First Launches For Yewtaxan Paclitaxel
9 April 1997
Bergen Brunswig Sues, And IVAX Countersues
7 April 1997
Nycomed Sees Profits Fall In 1996
3 March 1997
Acquisitions And Mergers Continue, Led By Novartis
6 January 1997
Nycomed Restructures At Nine Months
11 November 1996
Pretax Profits Down 26% At Nycomed
12 August 1996
Europe Stock Comment
8 July 1996
Profits Warning From Nycomed
1 July 1996
Europe Stock Comment
27 May 1996
Hafslund Nycomed Demerger
20 May 1996
Flat Profits At Hafslund Nycomed
13 May 1996
Europe Stock Comment
6 May 1996
Visipaque Approved In USA
29 April 1996
B-MS Representative Office In Estonia
22 April 1996
Nycomed Imagers Near Market In Japan
15 April 1996
New Company Formed By Nycomed Imaging
8 April 1996
Mergermania In Euro Drug Industry: Will It Continue?
18 March 1996
Strong 1995 Results For Hafslund Nycomed
26 February 1996
New Vitamin D Analog For Psoriasis In UK
19 February 1996
Hafslund Nycomed To Demerge
8 January 1996
Major M&As in 1995 As UK Industry Consolidates
8 January 1996
European Stock Comment
27 November 1995
Ivax 3rd quarter results
27 November 1995
Ivax/Hafslund Nycomed Merger Is Off
20 November 1995
Boots Doubles BASF Sales In US Drug Market
13 November 1995
Ivax Nycomed, A Defensive Merger?
6 November 1995
Generics, Diagnostics Leaders Ivax And Nycomed Merge
23 October 1995
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
